Clinical Trial: Autologous Stem Cell Rescue for Primary Amyloidosis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: High Dose Chemotherapy and Autologous Stem Cell Rescue for Primary Amyloidosis

Brief Summary: To evaluate the role of high dose therapy and autologous hematopoietic cell transplant for amyloidosis.

Detailed Summary: To learn about the use of high dose chemotherapy followed by transplantation using peripheral blood stem cells.
Sponsor: Stanford University

Current Primary Outcome: To evaluate the role of high dose therapy and autologous hematopoietic cell transplant for amyloidosis

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Stanford University

Dates:
Date Received: September 13, 2005
Date Started: April 1998
Date Completion:
Last Updated: September 10, 2010
Last Verified: September 2010